Whittier Trust Co. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 66,732 shares of the healthcare conglomerate’s stock after buying an additional 1,810 shares during the quarter. Whittier Trust Co.’s holdings in UnitedHealth Group were worth $13,069,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group during the second quarter worth about $110,000. Kings Point Capital Management increased its stake in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group during the second quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC purchased a new stake in UnitedHealth Group during the second quarter worth about $121,000. 85.97% of the stock is currently owned by institutional investors.

UnitedHealth Group Incorporated (NYSE UNH) opened at $222.38 on Thursday. The company has a market cap of $215,171.75, a P/E ratio of 23.13, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a one year low of $156.09 and a one year high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company earned $2.17 earnings per share. equities research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 33.26%.

In other news, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Insiders sold 34,630 shares of company stock valued at $7,669,416 over the last three months. Corporate insiders own 0.89% of the company’s stock.

A number of analysts have issued reports on the stock. Wells Fargo & Company reiterated an “outperform” rating and set a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. BMO Capital Markets assumed coverage on shares of UnitedHealth Group in a research note on Monday, October 16th. They set an “outperform” rating and a $250.00 price target on the stock. Citigroup boosted their price target on shares of UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Finally, Jefferies Group reiterated a “buy” rating and set a $248.00 price target on shares of UnitedHealth Group in a research note on Friday, December 1st. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average price target of $224.56.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Holdings Lifted by Whittier Trust Co.” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/12/21/unitedhealth-group-incorporated-unh-holdings-lifted-by-whittier-trust-co.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.